Clinical Trials Browser

Not yet recruiting × iberdomide × Plasma cell × Clear all

NCT05527340 2022-09-02

Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.

Phase 2 Not yet recruiting

Multiple Myeloma